Reviewing Bullfrog AI (NASDAQ:BFRG) and Mitesco (OTCMKTS:MITI)

Bullfrog AI (NASDAQ:BFRG) and Mitesco (OTCMKTS:MITI) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, risk, earnings and dividends.

Institutional & Insider Ownership

1.0% of Bullfrog AI shares are held by institutional investors. Comparatively, 0.0% of Mitesco shares are held by institutional investors. 25.2% of Bullfrog AI shares are held by insiders. Comparatively, 4.9% of Mitesco shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Bullfrog AI and Mitesco, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bullfrog AI	1	0	0	0	1.00
Mitesco	0	0	0	0	0.00

Volatility and Risk

Bullfrog AI has a beta of -2.29, indicating that its share price is 329% less volatile than the S&P 500. Comparatively, Mitesco has a beta of 5.6, indicating that its share price is 460% more volatile than the S&P 500.

Valuation & Earnings

This table compares Bullfrog AI and Mitesco”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bullfrog AI	$120,000.00	112.89	-$6.50 million	($0.63)	-1.70
Mitesco	$40,000.00	39.23	-$2.51 million	($0.14)	-0.65

Mitesco has lower revenue, but higher earnings than Bullfrog AI. Bullfrog AI is trading at a lower price-to-earnings ratio than Mitesco, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Bullfrog AI and Mitesco’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Bullfrog AI	N/A	-273.24%	-208.55%
Mitesco	-7,638.20%	N/A	-2,270.77%

Summary

Bullfrog AI beats Mitesco on 7 of the 12 factors compared between the two stocks.

About Bullfrog AI

Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data. It also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. The company was founded in 2017 and is based in Gaithersburg, Maryland.

About Mitesco

Mitesco, Inc. does not have significant operations. Previously, it was engaged in healthcare technology and services business. Mitesco, Inc. is based in Vero Beach, Florida.